HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic effect of BDNF-overexpressing human neural stem cells (HB1.F3.BDNF) in a rodent model of middle cerebral artery occlusion.

Abstract
Ischemic stroke mainly caused by middle cerebral artery occlusion (MCAo) represents the major type of stroke; however, there are still very limited therapeutic options for the stroke-damaged patients. In this study, we evaluated the neurogenic and therapeutic potentials of human neural stem cells (NSCs) overexpressing brain-derived neurotrophic factor (HB1.F3.BDNF) following transplantation into a rodent model of MCAo. F3.BDNF human NSCs (F3.BDNF) were transplanted into the contralateral side of striatum at 7 days after MCAo, and the transplanted animals were monitored up to 8 weeks using animal MRI and various behavioral tests before they were sacrificed for immunohistochemical analysis. Interestingly, animal MRI results indicate that the majority of contralaterally transplanted neural stem cells were migrated to the peri-infarct area, showing a pathotropism. Transplanted animals exhibited significant behavioral improvements in stepping, rotarod, and modified neurological severity score (mNSS) tests. We also found that the transplanted human cells were colocalized with nestin, DCX, MAP2, DARPP-32, TH, GAD65/67-positive cells, of which results can be correlated with neural regeneration and behavioral recovery in the transplanted animals. More importantly, we were able to detect high levels of human BDNF protein expression, presumably derived from the transplanted F3.BDNF. Taken together, these results provide strong evidence that human neural stem cells (F3.BDNF) are effective in treating stroke animal models.
AuthorsDa-Jeong Chang, Nayeon Lee, Chunggab Choi, Iksoo Jeon, Seung-Hun Oh, Dong Ah Shin, Tae-Sun Hwang, Hong J Lee, Seung U Kim, Hyeyoung Moon, Kwan Soo Hong, Kyung-Sun Kang, Jihwan Song
JournalCell transplantation (Cell Transplant) Vol. 22 Issue 8 Pg. 1441-52 ( 2013) ISSN: 1555-3892 [Electronic] United States
PMID23044072 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Brain-Derived Neurotrophic Factor
  • Dcx protein, rat
  • Doublecortin Protein
Topics
  • Animals
  • Behavior, Animal
  • Brain-Derived Neurotrophic Factor (metabolism, therapeutic use)
  • Cell Line
  • Cell Movement
  • Cell Tracking
  • Disease Models, Animal
  • Doublecortin Protein
  • Humans
  • Immunohistochemistry
  • Infarction, Middle Cerebral Artery (drug therapy, pathology)
  • Magnetic Resonance Imaging
  • Male
  • Models, Biological
  • Neural Stem Cells (cytology, metabolism, transplantation)
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: